Leaflet UFT 100mg / 224mg capsules

Product code: W42670001 Quantity: 21

Indicated for: cancer

Route of administration: oral

Substance: tegafur + uracil (antineoplastic agents)

ATC: L01BC53 (Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues)

Precautions:
Fertility warning
Fertility warning

This medicine may affect fertility.

Dose adjustment in hepatic impairment
Dose adjustment in hepatic impairment

Dose adjustment may be needed in liver disease.

Cytotoxic / special handling
Cytotoxic / special handling

Handle with special care.

Contraception required
Contraception required

Effective contraception is required during treatment.

Contraindicated during breastfeeding
Contraindicated during breastfeeding

Do not use this medicine while breastfeeding.

Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Hepatotoxicity
Hepatotoxicity

This medicine may affect the liver.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Myelosuppression / agranulocytosis
Myelosuppression / agranulocytosis

This medicine may lower blood cell counts.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Severe skin reactions
Severe skin reactions

Stop taking the medicine and seek urgent medical help if a severe rash occurs.

This combination of tegafur and uracil is used for the treatment of certain types of cancer, such as colorectal cancer. Tegafur is a prodrug of 5-fluorouracil (5-FU), while uracil is added to inhibit the degradation of 5-FU, thereby increasing the efficacy of the treatment.

The medication is taken orally, usually twice daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and undergo regular medical check-ups to monitor the response to treatment.

Patients should be aware of potential side effects, such as nausea, diarrhea, or a decrease in blood cell counts. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, diarrhea, fatigue, and loss of appetite. In rare cases, severe reactions such as myelosuppression or gastrointestinal toxicity may occur. Patients should be informed of these risks before starting treatment.

General data about UFT 100mg / 224mg

  • Substance: tegafur + uracil
  • Date of latest medicines list: 01-07-2013
  • Product code: W42670001
  • Concentration: 100mg / 224mg
  • Pharmaceutical form: capsules
  • Quantity: 21
  • Product type: Original
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.